Online inquiry

IVTScrip™ mRNA-Human ANKS4B, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK16139MR)

This product GTTS-WK16139MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKS4B protein. This product can be used in Oogenesis phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_145865.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 257629
UniProt ID Q8N8V4
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKS4B, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK16139MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK28540MR IVTScrip™ mRNA-Human APOPT1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA APOPT1
GTTS-WK24504MR IVTScrip™ mRNA-Human ASCC3, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ASCC3
GTTS-WK19138MR IVTScrip™ mRNA-Human ANKS3, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ANKS3
GTTS-WK26834MR IVTScrip™ mRNA-Human ARL13B, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARL13B
GTTS-WK2228MR IVTScrip™ mRNA-Human D105, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA D105
GTTS-WK7771MR IVTScrip™ mRNA-Human ADRM1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADRM1
GTTS-WK27464MR IVTScrip™ mRNA-Human ARNTL2, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARNTL2
GTTS-WK17004MR IVTScrip™ mRNA-Human ANKRD18A, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANKRD18A
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW